| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | GSK269962A | GDSC1000 | pan-cancer | AAC | -0.024 | 0.5 |
| mRNA | KIN001-270 | GDSC1000 | pan-cancer | AAC | -0.025 | 0.5 |
| mRNA | BRD9876:MK-1775 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.1 | 0.5 |
| mRNA | BRD-A94377914 | CTRPv2 | pan-cancer | AAC | -0.032 | 0.5 |
| mRNA | WZ4002 | CTRPv2 | pan-cancer | AAC | 0.032 | 0.5 |
| mRNA | MK-2206 | GDSC1000 | pan-cancer | AAC | 0.026 | 0.5 |
| mRNA | VX-702 | GDSC1000 | pan-cancer | AAC | -0.025 | 0.5 |
| mRNA | R428 | CTRPv2 | pan-cancer | AAC | 0.032 | 0.5 |
| mRNA | dabrafenib | GDSC1000 | pan-cancer | AAC | -0.021 | 0.5 |
| mRNA | 3-Cl-AHPC | CTRPv2 | pan-cancer | AAC | 0.024 | 0.5 |